Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;9(3):844-848.
doi: 10.21037/gs-2019-ra-05.

Robotic adrenalectomy in patients with pheochromocytoma: a systematic review

Affiliations
Review

Robotic adrenalectomy in patients with pheochromocytoma: a systematic review

Florence Bihain et al. Gland Surg. 2020 Jun.

Abstract

Pheochromocytomas (PHEOs) are neural crest cell tumors producing catecholamines. PHEOS need to be early diagnosed and adequately managed. Adrenalectomy is the gold standard treatment of these type of tumors. There has been major improvement of surgical technologies with the development of laparoscopic and robotic systems these past several years. We conducted a review of the literature to evaluate the robotic approach for adrenalectomy for patients with PHEO.

Keywords: Pheochromocytoma; adrenalectomy; hemodynamic instability; laparoscopy; morbidity; robotics.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/gs-2019-ra-05). The series “Robotic Adrenalectomy”was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.

References

    1. Farrugia FA, Martikos G, Tzanetis P, et al. Pheochromocytoma, diagnosis and treatment: Review of the literature. Endocr Regul 2017;51:168-81. 10.1515/enr-2017-0018 - DOI - PubMed
    1. Ilias I, Divgi C, Pacak K. Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer. Semin Nucl Med 2011;41:364-8. 10.1053/j.semnuclmed.2011.03.003 - DOI - PMC - PubMed
    1. Brunaud L, Bresler L, Ayav A, et al. Robotic-assisted adrenalectomy: what advantages compared to lateral transperitoneal laparoscopic adrenalectomy? Am J Surg 2008;195:433-8. 10.1016/j.amjsurg.2007.04.016 - DOI - PubMed
    1. Karabulut K, Agcaoglu O, Aliyev S, et al. Comparison of intraoperative time use and perioperative outcomes for robotic versus laparoscopic adrenalectomy. Surgery 2012;151:537-42. 10.1016/j.surg.2011.09.047 - DOI - PubMed
    1. Morino M, Benincà G, Giraudo G, et al. Robot-assisted vs laparoscopic adrenalectomy: A prospective randomized controlled trial. Surg Endosc 2004;18:1742-6. 10.1007/s00464-004-9046-z - DOI - PubMed